Victor Moreno, M.D., PhD is the Director of Clinical Research at START Madrid-FJD. He obtained this Medical Degree by the University Complutense of Madrid in 2004 and completed his specialized formation in Medical Oncology at Hospital Universitario La Paz during 2005 and 2009. During 2008-2010 he obtained his Masters Degree in Molecular Oncology by the CNIO (Spanish National Cancer Research Centre, Madrid). He obtained his PhD Doctorate, with European Mention and highest commendation in 2013 for his translational research in rectal cancer.
Dr. Moreno obtained the Excellent Resident Grant, which was awarded to complete his training in Phase I oncology clinical trials in the Drug Development Unit of the Royal Marsden Hospital (Sutton, UK) during 2010-2011.

After the completion of his Fellowship, he returned to a Consultant position for Medical Oncology to the Hospital Universitario La Paz where he was a member of the Neuro-Oncology and Gastrointestinal Tumors section and coordinator of the Oncology Phase I Unit. In 2013 he joined the START program in the new center START Madrid-Fundación Jimenez Diaz (FJD) as a Clinical Researcher dedicated exclusively to early clinical trials and drug development with special focus on targeted therapies, cancer immunotherapy and adoptive cell therapy.

Dr. Moreno has been a recipient of several awards and grants including 2011 ASCO Merit Award and Grant in 2011 for the 13th Joint ECCO – AACR – EORTC – ESMO Workshop on “Methods in Clinical Cancer Research” and is a member of the Executive Committee of the +MIR group in the Spanish Society of Medical Oncology (SEOM). He has co-authored more than 40 scientific papers published in the most relevant medical journals such as New England Journal of Medicine, Lancet Oncology, Journal of Clinical Oncology, Clinical Cancer Research and Nature.